5 completed, 1 active not recruiting, 1 terminated, 1 withdrawn. 8 Phase 2, 3 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 5, Active not recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 3 | 3 | Completed 2, Active not recruiting 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Ativan: new trials by email Literature Review of Ativan trials Research Report on Ativan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Therapies for Down Syndrome Regression Disorder Lorazepam, Intravenous immunoglobulin (IVIG), Tofacitinib - Down Syndrome, Regression | Phase 2 | Completed | University of Colorado, Denver | 66 | 2023-06-29 | 2026-09-03 |
| Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care Haloperidol, Lorazepam, Placebo - Delirium, Locally Advanced Malignant Neoplasm | Phase 2 / Phase 3 | Active not recruiting | M.D. Anderson Cancer Center | 110 | 2019-07-17 | 2026-06-15 |
| Benzodiazepines for the Reduction of Distress and Pain During and After Emergency Department Care Placebos, Lorazepam - Acute Pain | Phase 2 | Terminated | Maria Pacella | 1 | 2019-01-25 | 2020-03-09 |
| Sunitinib or Cediranib for Alveolar Soft Part Sarcoma Cediranib, Sunitinib, Prochlorperazine - Sarcoma, Alveolar Soft Part | Phase 2 | Completed | National Cancer Institute (NCI) | 34 | 2011-07-18 | 2026-02-02 |
| Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2) lorazepam or diazepam - Status Epilepticus | Phase 2 / Phase 3 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 259 | 2008-02-01 | 2012-12-18 |
| Effects of Pentazocine Versus Lorazepam on Manic Symptoms Pentazocine, Lorazepam - Bipolar Disorder, Schizoaffective Disorder | Phase 2 | Completed | Mclean Hospital | 19 | 2007-01-01 | 2019-03-06 |
| Lorazepam Sedation for Critically Ill Children Lorazepam, Midazolam, Lorazepam CI - Critical Illness | Phase 2 / Phase 3 | Completed | The Emmes Company, LLC | 179 | 2004-09-01 | 2023-03-20 |
| GHB Withdrawal Symptoms and Effectiveness of Treatment With Lorazepam Versus Pentobarbital - 1 Lorazepam, Pentobarbital - Substance-Related Disorders | Phase 1 / Phase 2 | Withdrawn | University of California, Los Angeles | 2004-08-01 | 2016-05-12 |
Acute Pain (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Bipolar Disorder (1) · Catatonia (1) · Critical Illness (1) · Delirium (1) · Down Syndrome (1) · Mania (1) · Neoplasm Metastasis (1) · Psychotic Disorders (1) · Recurrence (1) · Sarcoma, Alveolar Soft Part (1) · Status Epilepticus (1) · Substance-Related Disorders (1)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · M.D. Anderson Cancer Center (1) · Maria Pacella (1) · Mclean Hospital (1) · National Cancer Institute (NCI) (1) · The Emmes Company, LLC (1) · University of California, Los Angeles (1) · University of Colorado, Denver (1)
United States (8) · Brazil (1) · Canada (1)
Alice P Chen, M.D. (1) · Beth L Murphy, MD/PhD (1) · David Hui (1) · Elise Sannar, MD (1) · James Chamberlain, MD (1) · Jeffrey L Blumer, MD, PhD (1) · Joaquin Espinosa, PhD (1) · Jonathon Santoro, MD (1) · Karen Miotto, M.D. (1) · Maria L Pacella, PhD (1)
PMID 24756515, PMID 27993298, PMID 36302173, PMID 40742738
K23DA014291 (1)